Investigating new treatments for pain management.
Official title: SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)
Funded at Psychogenics, INC. · NIH-11211245 · Data updated 2026-11-12
This study is looking for new ways to help manage pain better, and it could lead to improved treatments for people dealing with chronic pain.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Psychogenics, INC. NIH-funded |
| Lab location | 1 site (Paramus, UNITED STATES) |
| Project start | September 6, 2024 |
| Project end | September 5, 2026 |
| Funding year | 2024 |
| Award (this year) | $11,772,171 |
| NIH project number | 75N95024D00038-0-759502400001-1 |
| Project ID | NIH-11211245 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals experiencing chronic pain conditions who are seeking new treatment options.
✕Less likely to help
Patients with acute pain or those who do not experience chronic pain may not receive benefit from this research.
What this research studies
This research focuses on identifying and testing new investigational agents that could improve pain management. By utilizing the NINDS Preclinical Screening Platform for Pain, the study aims to understand the underlying mechanisms of pain and evaluate potential therapies. Patients may benefit from advancements in pain control strategies that arise from this research, which seeks to enhance clinical practices and outcomes for those suffering from chronic pain.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for managing chronic pain.
How similar studies have gone: Other research initiatives have shown promise in developing new pain management strategies, indicating that this approach could yield significant advancements.
Where this research is happening
-
Psychogenics, INC.
Paramus, United States Active
Researchers
- Principal investigator: Hanania, Taleen — Psychogenics, INC.
- Study coordinator: Hanania, Taleen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.